Enlivex Therapeutics Ltd.
Therapeutic apoptotic cell preparations, method for producing same and uses thereof
Last updated:
Abstract:
The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses. The pharmaceutical compositions may be used in treatment of conditions such as, but not limited to, graft versus host disease (GVHD) and autoimmune diseases including but not limited to inflammatory bowel disease, gout and arthritis.
Status:
Grant
Type:
Utility
Filling date:
29 Jul 2018
Issue date:
23 Feb 2021